Neonatal THC and TRKB: Why Transcript Changes Are Not Proof of Permanent Brain Injury
A neonatal mouse experiment found altered neurotrophic signaling markers after THC exposure, but it did not establish permanent human brain injury. RNA measurements, protein markers, and later behavior are different levels of evidence.
Age, dose, and timing define the model
Philippot and colleagues administered THC to male mice on postnatal day 10 and examined brain regions 24 hours later. The experiment measured transcripts related to neurotrophic, cannabinoid, synaptic, and oxidative-stress pathways, along with a protein marker associated with apoptosis.
This was direct neonatal animal dosing. It should not be described as a study measuring the dose received by breastfed human infants or as a human prenatal exposure cohort.
Which outcomes changed?
The higher THC dose reduced Trkb transcript levels in cortical regions. The hippocampal comparison requires care: the post-hoc comparison was significant, while its overall analysis of variance narrowly missed the conventional significance threshold.
Synaptophysin and PSD95 transcript measures did not significantly change across the assessed regions. A frontal-cortex BAX finding supplied a separate apoptosis-related signal; it was not a direct count demonstrating widespread permanent neuronal loss.
What remains to be connected?
The authors explicitly identify uncertainty about whether the Trkb transcript finding translates into altered TRKB protein. Earlier behavioral experiments provide context, but their observations are not additional behavioral measurements in this molecular experiment.
Developmental stages and injected doses cannot be mapped directly onto a particular child’s exposure. The study supports mechanistic investigation, while leaving unanswered questions about persistence, functional consequences, human dose-response, and causation in an individual case.
Related reading: why cannabis effects can differ across memory tests.
Primary research
Gaëtan Philippot; Erica Forsberg; Caroline Tahan; Henrik Viberg; Robert Fredriksson. A Single δ9-Tetrahydrocannabinol (THC) Dose During Brain Development Affects Markers of Neurotrophy, Oxidative Stress, and Apoptosis. Frontiers in Pharmacology (2019). DOI: 10.3389/fphar.2019.01156.
